|
|
|
||
Filed by the Registrant þ
|
||||
Filed by a Party other than the Registrant o
|
||||
Check the appropriate box: |
||||
o |
|
Preliminary Proxy Statement |
||
o
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
||
þ
|
|
Definitive Proxy Statement
|
||
o
|
|
Definitive Additional Materials
|
||
o
|
|
Soliciting Material Pursuant to §240.14a-12
|
||
|
|
|
|
|
NU SKIN ENTERPRISES, INC.
|
||||
(Name of Registrant as Specified In Its Charter)
|
||||
|
||||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
||||
Payment of Filing Fee (Check the appropriate box): |
||||
þ
|
|
No fee required.
|
||
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
||
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
o
|
|
Fee paid previously with preliminary materials.
|
||
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing Party:
|
|
|
(4)
|
|
Date Filed:
|
1. | To elect the eight directors named in the Proxy Statement; |
3. | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2014; and |
4. | To transact such other business as may properly come before the Annual Meeting. |
1. | To elect the eight directors named in the Proxy Statement; |
3. | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2014; and |
4. | To transact such other business as may properly come before the Annual Meeting. |
Number of Shares
|
%
|
|||
Truman Hunt (1)
|
|
816,899
|
|
1.4
|
Steven Lund (2)
|
|
605,897
|
|
1.0
|
Joseph Chang (3)
|
|
308,719
|
|
*
|
Daniel Chard (4)
|
|
278,269
|
*
|
|
Matt Dorny (5)
|
|
216,944
|
|
*
|
Ritch Wood (6)
|
|
195,628
|
|
*
|
Andrew Lipman (7)
|
103,053
|
*
|
||
Daniel Campbell (8)
|
|
80,000
|
*
|
|
Thomas Pisano (9)
|
|
45,653
|
|
*
|
Nevin Andersen (10)
|
|
37,153
|
*
|
|
Neil Offen (11)
|
|
12,442
|
|
*
|
Patricia Negrón
|
|
5,942
|
*
|
|
Vanguard Group, Inc. (12)
|
|
3,765,082
|
|
6.4
|
The London Company (13)
|
|
2,938,320
|
|
5.0
|
All directors and executive officers as a group (13 persons) (14)
|
|
2,855,790
|
|
4.8
|
|
|
|
|
|
* | Less than 1% |
(1) | Includes 568,750 shares of Class A Common Stock that Mr. Hunt had the right to acquire within 60 days. |
(2) | Includes 548,676 shares of Class A Common Stock held by a family limited liability company. Mr. and Mrs. Lund are co–managers of the limited liability company and share voting and investment power with respect to all shares held by the limited liability company. Also includes 7,221 shares of Class A Common Stock held indirectly by Mr. Lund as co‑trustee with respect to which he has shared voting and investment power, for which Mr. Lund disclaims beneficial ownership. Also includes 50,000 shares of Class A Common Stock that Mr. Lund had the right to acquire within 60 days. |
(3) | Includes 248,437 shares of Class A Common Stock that Mr. Chang had the right to acquire within 60 days. |
(4) | Includes 244,999 shares of Class A Common Stock that Mr. Chard had the right to acquire within 60 days. |
(5) | Includes 186,999 shares of Class A Common Stock that Mr. Dorny had the right to acquire within 60 days. |
(6) | Includes 157,499 shares of Class A Common Stock that Mr. Wood had the right to acquire within 60 days. |
(7) | Includes 70,100 shares of Class A Common Stock that Mr. Lipman had the right to acquire within 60 days. |
(8) | Includes 40,000 shares of Class A Common Stock that Mr. Campbell had the right to acquire within 60 days. |
(9) | Includes 10,000 shares of Class A Common Stock that Mr. Pisano had the right to acquire within 60 days. |
(10) | Includes 30,100 shares of Class A Common Stock that Mr. Andersen had the right to acquire within 60 days. |
(11) | Includes 10,000 shares of Class A Common Stock that Mr. Offen had the right to acquire within 60 days. |
(12) | The information regarding the number of shares beneficially owned or deemed to be beneficially owned by Vanguard Group, Inc. was taken from a Schedule 13G filed by that entity with the Securities and Exchange Commission on February 12, 2014. The address of Vanguard Group, Inc. is 100 Vanguard Blvd, Malvern, PA 19355. |
(13) | The information regarding the number of shares beneficially owned or deemed to be beneficially owned by The London Company was taken from a Schedule 13G filed by that entity with the Securities and Exchange Commission on February 6, 2013. The address of The London Company is 1801 Bayberry Court, Suite 301, Richmond, VA 23226. |
(14) | Includes 1,733,133 shares of Class A Common Stock that all of our executive officers and directors as a group had the right to acquire within 60 days. |
Nevin Andersen
|
Andrew Lipman
|
Thomas Pisano
|
Daniel Campbell
|
Patricia Negrón
|
Neil Offen
|
·
|
major financial risk exposures;
|
·
|
operational risks related to information systems and facilities; and
|
·
|
public disclosure and investor related risks.
|
·
|
operational risks not assigned to the Audit Committee;
|
·
|
compliance and regulatory risks; and
|
·
|
reputational risks.
|
·
|
compensation practices related risks; and
|
·
|
human resources risks.
|
Director
|
Audit
|
Executive
Compensation
|
Nominating and
Corporate Governance
|
Nevin Andersen
|
X*
|
|
X
|
Daniel Campbell
|
X
|
X*
|
|
Andrew Lipman
|
|
X
|
X*
|
X
|
X
|
|
|
Neil Offen
|
|
X
|
X
|
Thomas Pisano
|
X
|
|
X
|
|
|
|
|
Number of Meetings in 2013
|
7
|
10
|
10
|
|
|
|
|
* | Committee chair |
·
|
selecting our independent auditor;
|
·
|
reviewing the activities and the reports of our independent auditor;
|
·
|
approving in advance the audit and non-audit services provided by our independent auditor;
|
·
|
reviewing our quarterly and annual financial statements and our significant accounting policies, practices and procedures;
|
·
|
reviewing the adequacy of our internal controls and internal auditing methods and procedures;
|
·
|
overseeing our compliance with legal and regulatory requirements;
|
·
|
overseeing our risk assessment and risk management programs and plans related to our major financial risk exposures, operational risks related to information systems and facilities, and public disclosure and investor related risks; and
|
·
|
conferring with the chairs of the Nominating and Corporate Governance Committee and Executive Compensation Committee regarding their respective oversight of our risk assessment and risk management programs and our related guidelines and policies.
|
·
|
overseeing and approving compensation policies and programs;
|
·
|
reviewing and approving corporate goals and objectives relevant to the compensation to be paid to our Chief Executive Officer and other executive officers;
|
·
|
establishing the salaries, bonuses, and other compensation to be paid to our Chief Executive Officer as well as approving the compensation for the other executive officers;
|
·
|
administering our incentive plans;
|
·
|
overseeing regulatory compliance with respect to executive compensation matters; and
|
·
|
overseeing our risk assessment and risk management programs and plans related to our compensation practices and human resources.
|
·
|
making recommendations to the Board of Directors about the size and membership criteria of the Board of Directors or any committee thereof;
|
·
|
identifying and recommending candidates for the Board of Directors and committee membership, including evaluating director nominations received from stockholders;
|
·
|
leading the process of identifying and screening candidates for a new chief executive officer when necessary, and evaluating the performance of the chief executive officer;
|
·
|
determining compensation for the Board of Directors and overseeing the evaluation of the Board of Directors and management;
|
·
|
developing and recommending to the Board a set of corporate governance guidelines; and
|
·
|
overseeing our risk assessment and risk management programs and plans related to our corporate governance risks, operational risks not assigned to the Audit Committee, compliance and regulatory risks, and reputational risks.
|
Name
|
Fees Earned or
Paid in Cash
($) |
Stock
Awards ($)(1) |
Option
Awards ($)(1) |
All Other
Compensation
($) |
Total
($) |
Nevin Andersen
|
124,500
|
56,780
|
77,100
|
—
|
258,380
|
Daniel Campbell
|
142,500
|
56,780
|
77,100
|
—
|
276,380
|
Andrew Lipman
|
127,000
|
56,780
|
77,100
|
—
|
260,880
|
Patricia Negron
|
104,000
|
56,780
|
77,100
|
—
|
237,880
|
Thomas Pisano
|
105,500
|
56,780
|
77,100
|
—
|
239,380
|
Neil Offen
|
104,000
|
56,780
|
77,100
|
—
|
237,880
|
Steven Lund
|
—
|
—
|
1,089,000
|
1,298,573
|
2,387,573
|
(1) | During the fiscal year ended December 31, 2013, Messrs. Andersen, Campbell, Lipman, Pisano and Offen and Ms. Negrón each received 1,000 restricted stock units and 5,000 stock options. During the fiscal year ended December 31, 2013, Mr. Lund received 50,000 performance stock options, which vest in four equal tranches based on the achievement of $6.00, $8.00, $10.00 and $12.00 earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The amounts reported in these columns reflect the aggregate grant date fair value of equity awards computed in accordance with FASB ASC Topic 718 and do not represent amounts actually received by the director. For this purpose, the estimate of forfeitures is disregarded and the value of the stock awards is discounted to reflect that no dividends are paid prior to vesting. For information on the valuation assumptions used in calculating these amounts, refer to Note 11 to our financial statements in the Form 10-K filed for the fiscal year ended December 31, 2013. |
Name
|
Stock Awards
|
Option Awards
|
Nevin Andersen
|
1,000
|
35,100
|
Daniel Campbell
|
1,000
|
45,000
|
Andrew Lipman
|
1,000
|
75,100
|
Patricia Negron
|
1,000
|
10,000
|
Thomas Pisano
|
1,000
|
15,000
|
Neil Offen
|
1,000
|
15,000
|
Steven Lund
|
10,416
|
100,000
|
(2) | For Mr. Lund the All Other Compensation, column reports Mr. Lund's compensation as an employee of the company for 2013, including a salary of $550,000, an incentive plan bonus of $660,000, a discretionary holiday bonus of $24,216, and other compensation of $64,357, including $8,350 in life insurance premiums and 401(k) contributions of $28,000 and our incremental cost for perquisites and personal benefits including company products, gifts at company parties, spouse travel to corporate and sales force events where the spouse is expected to attend and help entertain and participate in events with our employees or sales force and their spouses and $2,521 for tax payments for corporate and sales force event related spouse travel. |
·
|
Continued development of our anti-aging product platform, with plans for the development and launch of new products over the next several years;
|
·
|
The global limited-time offer of our ageLOC TR90 weight management system, which generated approximately $550 million in revenue; and
|
·
|
Accelerated sales force and consumer growth.
|
·
|
our compensation objectives;
|
·
|
various components of our compensation program and how they relate to our compensation objectives;
|
·
|
factors taken into consideration in establishing executive compensation; and
|
·
|
decisions related to the 2013 compensation of our Chief Executive Officer, our Chief Financial Officer, and the other executive officers listed in the Summary Compensation Table (the "named executive officers"), and the factors and analysis pertaining to such decisions.
|
·
|
successfully recruit, motivate and retain experienced and talented executives;
|
·
|
provide competitive compensation arrangements that are tied to corporate and individual performance; and
|
·
|
align the financial interests of our executives with those of our stockholders.
|
Component of Compensation Program
|
Objective
|
Base Salary
|
Pay for role
Retention
|
Recruitment
|
|
Cash Incentive Plan
|
Short–term incentive
Pay for performance
Quarterly and annual operating achievement
|
Equity Incentive Plan
|
Long-term incentive
Pay for performance
Stock price performance
Stockholder alignment
|
Alberto Culver Company
|
Nutrisystem, Inc.
|
Church & Dwight Co., Inc.
|
Perrigo Company
|
Elizabeth Arden, Inc.
|
Revlon, Inc.
|
Energizer Holdings, Inc.
|
Sally Beauty Holdings, Inc.
|
The Hain Celestial Group, Inc.
|
Sensient Technologies Corporation
|
Helen of Troy Limited
|
Tupperware Brands Corporation
|
Herbalife Ltd.
|
Ulta Salon, Cosmetics & Fragrance, Inc.
|
International Flavors and Fragrances Inc.
|
Vitamin Shoppe, Inc.
|
Newell Rubbermaid Inc.
|
Weight Watchers International, Inc.
|
·
|
Our global cash incentive compensation is based on revenue and operating income, which are core measures of performance. In addition, substantially all of our revenue is received through cash or credit card payments, which minimizes risk associated with our revenue-based incentives. We limit bonuses under our cash incentive plans to 200% of the target bonus. Additionally, the Board of Directors and management regularly review the business plans and strategic initiatives, including related risks, proposed to achieve such performance metrics.
|
·
|
We do not engage in speculative trading and we do not provide incentives for our management or employees to engage in such practices. In addition, our policies prohibit our employees and directors from holding our stock in margin accounts and from engaging in speculative transactions in our stock, including short sales, options or hedging transactions, with limited exceptions.
|
·
|
current market practices and salary levels;
|
·
|
each executive officer's responsibilities, experience in their position and capabilities;
|
·
|
individual performance and company performance;
|
·
|
the relative role and contribution of each executive officer in the company;
|
·
|
competitive offers made to executive officers and the level of salary that may be required to recruit or retain executive officers;
|
·
|
the recommendations of the Chairman of the Board and of the Chief Executive Officer regarding the other executive officers; and
|
·
|
prior-year financial performance and current-year performance projections.
|
Named
Executive Officer |
|
Prior Salary
($)
|
|
Adjusted Salary
($)
|
|
Increase
($)
|
|
Increase
(%)
|
|
|
|
|
|
|
|
|
|
|
|
Ritch Wood
|
|
480,000
|
|
510,000
|
|
30,000
|
|
6%
|
|
Daniel Chard
|
|
480,000
|
|
510,000
|
|
30,000
|
|
6%
|
|
Matthew Dorny
|
|
385,000
|
|
420,000
|
|
35,000
|
|
9%
|
|
|
|
Minimum
|
|
Goal
|
|
Stretch
|
Revenue
|
|
|
|
|
|
|
Percentage of goal performance level
|
|
95.4%
|
|
100.0%
|
|
108.0%
|
Percentage of target bonus paid
|
|
50.0%
|
|
100.0%
|
|
200.0%
|
|
|
Minimum
|
|
Goal
|
|
Stretch
|
Operating Income
|
|
|
|
|
|
|
Percentage of goal performance level
|
|
94.7%
|
|
100.0%
|
|
108.9%
|
Percentage of target bonus paid
|
|
50.0%
|
|
100.0%
|
|
200.0%
|
·
|
For actual performance between the minimum performance levels and the goal performance levels, the percentage of target bonus paid is equal to 100% – [(100% – 50%) x (actual performance – goal performance level) / (minimum performance level – goal performance level)].
|
·
|
For actual performance between the goal performance levels and the stretch performance levels, the percentage of target bonus paid is equal to 100% + [(200% – 100%) x (actual performance – goal performance level) / (stretch performance level – goal performance level)].
|
·
|
For actual performance exceeding the stretch performance levels, the percentage of target bonus paid is equal to 100% + (actual performance / stretch performance level).
|
Q1 2013
|
Q2 2013
|
Q3 2013
|
Q4 2013
|
Annual
|
|
Revenue
(50% weight) |
|
|
|
|
|
|
|
|
|
|
|
Goal performance level(1)
|
490,000
|
515,000
|
785,000
|
620,000
|
2,410,000
|
(Constant currency growth rate over prior year)
|
7.4%
|
-10.8%
|
51.0%
|
7.0%
|
13.0%
|
Actual performance
|
541,305
|
671,328
|
908,299
|
1,055,786
|
3,176,718
|
(Constant currency growth rate over prior year)
|
20.3%
|
16.2%
|
75.9%
|
90.1%
|
54.2%
|
Percentage of goal performance level achieved
|
110.5%
|
130.4%
|
115.7%
|
170.3%
|
131.8%
|
Percentage of target bonus paid
|
200.0%
|
200.0%
|
200.0%
|
200.0%
|
200.0%
|
|
|
|
|
|
|
Operating Income
(50% weight) |
|
|
|
|
|
|
|
|
|
|
|
Goal performance level(2)
|
74,000
|
80,000
|
134,000
|
95,500
|
383,500
|
(Constant currency growth rate over prior year)
|
3.3%
|
-18.3%
|
62.7%
|
7.4%
|
12.5%
|
Actual performance
|
82,659
|
114,583
|
168,275
|
188,595
|
554,112
|
(Constant currency growth rate over prior year)
|
9.8%
|
11.1%
|
86.3%
|
153.5%
|
66.1%
|
Percentage of goal performance level achieved
|
111.7%
|
143.2%
|
125.6%
|
197.5%
|
144.5%
|
Percentage of target bonus paid
|
200.0%
|
200.0%
|
200.0%
|
200.0%
|
200.0%
|
(1) | Minimum revenue performance levels for the four quarterly and annual periods were $470,000; $490,000; $745,000; $595,000 and $2,300,000; respectively. Stretch revenue performance levels were $527,000; $563,000; $845,000; $667,000 and $2,602,000; respectively. |
(2) | Minimum operating income performance levels for the four quarterly and annual periods were $70,000; $75,500; $126,500; $91,000 and $363,000; respectively. Stretch operating income performance levels were $80,000; $88,000; $146,000; $103,500 and $417,500; respectively. |
·
|
practices of peer companies;
|
·
|
degree of responsibility for overall corporate performance;
|
·
|
overall compensation levels;
|
·
|
changes in position and/or responsibilities;
|
·
|
individual performance;
|
·
|
company performance;
|
·
|
total stockholder return;
|
·
|
degree of performance risk in the equity grant program;
|
·
|
potential dilution of our overall equity grants;
|
·
|
accumulated realized and unrealized value of past accumulated equity awards;
|
·
|
associated expenses of equity awards;
|
·
|
the recommendations of the Chairman of the Board and of the Chief Executive Officer regarding the other executive officers; and
|
·
|
data and context provided by our compensation consultant.
|
·
|
likely gain in shareholder value if the annualized earnings per share goals are achieved;
|
·
|
performance requirement inherent in the annualized earnings per share goals;
|
·
|
potential financial statement expenses;
|
·
|
potential dilution of outstanding shares; and
|
·
|
annual grant value spread over the expected five-year life of the grant.
|
Percentage Performance-Based
|
||||||||||
Named
Executive Officer |
Performance
Stock Options
|
Performance
Restricted
Stock Units
|
Time-Vested
Stock Options
|
Number
of Awards
|
Grant Date
Fair Value |
|||||
|
|
|
|
|
|
|
|
|
|
|
Truman Hunt
|
|
75,000
|
|
75,000
|
|
50,000
|
|
75%
|
|
70%
|
Ritch Wood
|
|
92,500
|
|
10,000
|
|
27,500
|
|
79%
|
|
76%
|
Daniel Chard
|
|
92,500
|
|
10,000
|
|
27,500
|
|
79%
|
|
76%
|
Joseph Chang
|
|
57,500
|
|
5,000
|
|
12,500
|
|
83%
|
|
81%
|
D. Matthew Dorny
|
|
57,500
|
|
5,000
|
|
12,500
|
|
83%
|
|
81%
|
Principal Position
|
Year
|
|
Salary
($)(1)
|
|
Bonus
($)(2)
|
|
Stock
Awards
($)(3)
|
|
Option
Awards
($)(3)
|
|
Non-Equity
Incentive Plan
Compensation
($)(4)
|
|
All Other
Compensation
($)(5)
|
|
Total
($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Truman Hunt
President and Chief Executive Officer
|
2013
|
|
1,000,000
|
|
42,966
|
|
2,914,313
|
|
3,596,000
|
|
2,000,000
|
|
141,557
|
|
9,694,835
|
2012
|
|
988,333
|
|
42,167
|
|
3,934,500
|
|
685,000
|
|
2,000,000
|
|
129,965
|
|
7,779,965
|
|
2011
|
|
919,391
|
|
41,250
|
|
2,312,063
|
|
510,835
|
|
1,092,546
|
|
139,604
|
|
5,015,689
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ritch Wood
Chief Financial Officer
|
2013
|
|
505,000
|
|
22,550
|
|
388,575
|
|
2,528,063
|
|
612,000
|
|
92,426
|
|
4,148,614
|
2012
|
|
473,333
|
|
20,500
|
|
524,600
|
|
604,600
|
|
576,000
|
|
74,383
|
|
2,273,417
|
|
2011
|
|
435,000
|
|
18,833
|
|
308,275
|
|
432,109
|
|
310,142
|
|
81,477
|
|
1,585,836
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Daniel Chard
President, Global Sales and Operations
|
2013
|
|
505,000
|
|
22,550
|
|
388,575
|
|
2,528,063
|
|
612,000
|
|
87,547
|
|
4,143,735
|
2012
|
|
480,000
|
|
21,940
|
|
524,600
|
|
604,600
|
|
576,000
|
|
84,725
|
|
2,291,865
|
|
2011
|
|
422,500
|
|
43,208
|
|
308,275
|
|
432,109
|
|
299,569
|
|
72,831
|
|
1,578,492
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joseph Chang
Chief Scientific Officer and Executive Vice President, Product Development
|
2013
|
|
550,000
|
|
24,216
|
|
194,288
|
|
1,490,663
|
|
660,000
|
|
89,740
|
|
3,008,906
|
2012
|
|
545,833
|
|
24,806
|
|
262,300
|
|
268,475
|
|
660,000
|
|
93,408
|
|
1,854,822
|
|
2011
|
|
525,000
|
|
22,375
|
|
154,138
|
|
192,487
|
|
370,056
|
|
84,318
|
|
1,348,373
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
D. Matthew Dorny
General Counsel
|
2013
|
|
414,167
|
|
18,800
|
|
194,288
|
|
1,490,663
|
|
504,000
|
|
77,146
|
|
2,699,063
|
2012
|
|
385,000
|
|
16,542
|
|
262,300
|
|
268,475
|
|
462,000
|
|
57,033
|
|
1,451,350
|
|
2011
|
|
337,500
|
|
14,667
|
|
154,138
|
|
192,487
|
|
239,655
|
|
77,222
|
|
1,015,670
|
(1) | Mr. Chang deferred a portion of his salary under our nonqualified deferred compensation plan, which is included in the Nonqualified Deferred Compensation—2013 table. Each of the named executive officers also contributed a portion of his salary to our 401(k) retirement savings plan. |
(2) | The amounts reported in this column include gift payments that we have historically made to all corporate employees as year‑end holiday gifts in the form of a gift certificate or similar merchant credit arrangement, or cash in an amount equal to a percentage of each employee's base salary (approximately two weeks of salary). The amount reported in this column in 2011 for Mr. Chard includes a special discretionary bonus. |
(4) | The amounts reported in this column are cash awards to the named executive officers made pursuant to our Amended and Restated 2010 Omnibus Incentive Plan. See the "Compensation Discussion and Analysis—Cash Incentive Bonus" for information regarding these awards. Mr. Chang deferred a portion of his incentive bonuses under our nonqualified deferred compensation plan, which is included in the Nonqualified Deferred Compensation—2013 table. |
(5) | See the All Other Compensation Table below for additional information. |
Name
|
Company Contributions
to Deferred
Compensation Plan
($) |
Tax Payments
($)(1) |
Term Insurance Premiums
paid by
Company
($)(2) |
Company Contributions
to 401(k) Retirement
Savings Plan
($) |
Perquisites and Other Personal Benefits
($)(3) |
Other
($) |
Total
($) |
Truman Hunt
|
82,500
|
2,521
|
1,571
|
28,000
|
26,964
|
—
|
141,557
|
Ritch Wood
|
28,000
|
2,521
|
838
|
33,500
|
27,567
|
—
|
92,426
|
Daniel Chard
|
26,750
|
2,521
|
1,058
|
33,500
|
23,718
|
—
|
87,547
|
Joseph Chang
|
37,500
|
2,521
|
3,270
|
28,000
|
18,448
|
—
|
89,740
|
Matthew Dorny
|
19,350
|
2,107
|
1,016
|
33,500
|
21,173
|
—
|
77,146
|
(1) | This column reports amounts reimbursed by us for the payment of taxes with respect to travel of the named executive officers' spouses to sales force events where the spouse is expected to attend and help entertain and participate in events with our sales force and their spouses. We have elected not to pay the income taxes associated with non-business related perquisites. For further discussion regarding tax payments, see the "Compensation Discussion and Analysis—Perquisites and Other Personal Benefits" section above. |
(2) | This column reports premiums paid to obtain term life insurance policies with coverage, as of December 31, 2013, of $500,000 for Mr. Chang; $750,000 for Messrs. Hunt, Wood, Chard and Dorny. |
(3) | This column reports our incremental cost for perquisites and personal benefits provided to the named executive officers. In 2013, these included, among other things, the personal use of company‑provided vehicles, properties, sporting event tickets, company products, prizes at company parties, and spouse travel to sales force events where the spouse is expected to attend and help entertain and participate in events with our sales force and their spouses. |
Name
|
Grant Date
|
Estimated Future Payouts
under non-Equity
Incentive Plan Awards
|
Estimated Future Payouts
under Equity Incentive
Plan Awards
|
All Other
Stock Awards:
Number of Shares
of Stock or Units
(#)
|
All Other
Option Awards: Number of
Securities
Underlying Options
(#)(3)
|
Exercise or
Base Price of Option Awards
($)(4)
|
Grant Date
Fair Value of Stock and
Option Awards
($)(5)
|
||||
Threshold
($)(1)
|
Target
($)(1)
|
Max
($)(1)
|
Threshold
(#)(2)
|
Target
(#)(2)
|
Max
(#)(2)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Truman Hunt
|
2/15/2013
|
—
|
—
|
—
|
37,500
|
75,000
|
75,000
|
—
|
—
|
—
|
2,914,313
|
|
7/15/2013
|
—
|
—
|
—
|
18,750
|
75,000
|
75,000
|
—
|
—
|
77.65
|
1,633,500
|
|
12/9/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
50,000
|
131.52
|
1,962,500
|
|
N/A
|
250,000
|
1,000,000
|
2,000,000
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
Ritch Wood
|
2/15/2013
|
—
|
—
|
—
|
8,750
|
17,500
|
17,500
|
|
—
|
41.27
|
190,838
|
|
2/15/2013
|
—
|
—
|
—
|
5,000
|
10,000
|
10,000
|
—
|
—
|
—
|
388,575
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
13,750
|
41.27
|
164,038
|
|
7/15/2013
|
—
|
—
|
—
|
18,750
|
75,000
|
75,000
|
—
|
—
|
77.65
|
1,633,500
|
|
12/9/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
13,750
|
131.52
|
539,688
|
|
N/A
|
76,500
|
306,000
|
612,000
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
Daniel Chard
|
2/15/2013
|
—
|
—
|
—
|
8,750
|
17,500
|
17,500
|
—
|
—
|
41.27
|
190,838
|
|
2/15/2013
|
—
|
—
|
—
|
5,000
|
10,000
|
10,000
|
—
|
—
|
—
|
388,575
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
13,750
|
41.27
|
164,038
|
|
7/15/2013
|
—
|
—
|
—
|
18,750
|
75,000
|
75,000
|
—
|
—
|
77.65
|
1,633,500
|
|
12/9/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
13,750
|
131.52
|
539,688
|
|
N/A
|
76,500
|
306,000
|
612,000
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joseph Chang
|
2/15/2013
|
—
|
—
|
—
|
3,750
|
7,500
|
7,500
|
—
|
—
|
41.27
|
81,788
|
|
2/15/2013
|
—
|
—
|
—
|
2,500
|
5,000
|
5,000
|
—
|
—
|
—
|
194,288
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
6,250
|
41.27
|
74,563
|
|
7/15/2013
|
—
|
—
|
—
|
12,500
|
50,000
|
50,000
|
—
|
—
|
77.65
|
1,089,000
|
|
12/9/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
6,250
|
131.52
|
245,313
|
|
N/A
|
82,500
|
330,000
|
660,000
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
Matthew Dorny
|
2/15/2013
|
—
|
—
|
—
|
3,750
|
7,500
|
7,500
|
—
|
—
|
41.27
|
81,788
|
|
2/15/2013
|
—
|
—
|
—
|
2,500
|
5,000
|
5,000
|
—
|
—
|
—
|
194,288
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
6,250
|
41.27
|
74,563
|
|
7/15/2013
|
—
|
—
|
—
|
12,500
|
50,000
|
50,000
|
—
|
—
|
77.65
|
1,089,000
|
|
12/9/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
6,250
|
131.52
|
245,313
|
|
N/A
|
63,000
|
252,000
|
504,000
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
(2) | The awards reported in these columns are performance restricted stock units and performance stock options granted under our Amended and Restated 2010 Omnibus Incentive Plan. The amounts reported in these columns reflect the potential number of shares of stock that become eligible for vesting or exercisable pursuant to these performance equity awards if certain financial metrics are achieved. The amount reported in the Threshold column for each award reflects the potential number of shares of stock that become eligible for vesting or exercisable if performance is at the minimum level required for any shares of stock to become eligible for vesting or exercisable. The amount reported in both the Target and Max columns for each award reflect the potential number of shares of stock that become eligible for vesting or exercisable if performance is at the level required for all shares of stock to become eligible for vesting or exercisable. |
(3) | The awards reported in this column are stock options granted to the named executive officers under our Amended and Restated 2010 Omnibus Incentive Plan. These stock option awards vest and become exercisable in four equal annual installments beginning one year from the date of the respective grant. |
(4) | This column shows the exercise price for the stock option awards granted, which in each case is the closing price of our stock on the date of the respective grant. |
(5) | The amounts reported in this column reflect the aggregate grant date fair value of equity awards computed in accordance with FASB ASC Topic 718. For this purpose, the estimate of forfeitures is disregarded and the value of the stock awards is discounted to reflect that no dividends are paid prior to vesting. For information on the valuation assumptions used in calculating these amounts, refer to Note 11 to our financial statements in the Form 10-K filed for the fiscal year ended December 31, 2013. |
·
|
Time-based equity awards granted to the executive officers will fully vest upon certain terminations of employment within six months prior to and in connection with, or within two years following, a change in control;
|
·
|
No excise tax protections will be provided for termination payments;
|
·
|
The executive officers will be bound by certain covenants, including non-solicitation, non-competition and non-endorsement, that are in addition to, or supersede, previous key employee covenants;
|
·
|
The executive officers will be entitled to the following termination payments in addition to salary and benefits earned prior to termination:
|
(a)
|
A lump sum equal to the pro-rata portion of the executive officer's target bonus for any outstanding bonus cycle; and
|
(b)
|
Salary continuation for up to 90 days in certain circumstances related to a disability.
|
(a)
|
A lump sum equal to the cost of twelve months of health care continuation coverage;
|
(b)
|
A lump sum equal to the pro-rata portion of the executive officer's earned bonus, if any, for each outstanding bonus cycle;
|
(c)
|
For Mr. Hunt, continuation of annual salary for a period of 24 months; and
|
(d)
|
For Messrs. Wood, Chard and Dorny, continuation of annual salary for a period of 15 months.
|
(a)
|
A lump sum equal to the cost of twelve months of health care continuation coverage;
|
(b)
|
A lump sum equal to the pro-rata portion of the executive officer's target bonus for any outstanding bonus cycle;
|
(c)
|
For Mr. Hunt, a lump sum amount equal to two times annual salary and target bonus; and
|
(d)
|
For Messrs. Wood, Chard and Dorny, a lump sum amount equal to 1.25 times annual salary and target bonus.
|
(a)
|
For Mr. Hunt, continuation of annual salary for a restricted period of up to two years, during which non-solicitation, non-competition and non-endorsement covenants remain in effect; and
|
(b)
|
For Messrs. Wood, Chard and Dorny, continuation of 75% of annual salary for a restricted period of up to one year, during which non-solicitation, non-competition and non-endorsement covenants remain in effect.
|
·
|
Mr. Chang is entitled to annual retention bonuses for continued employment at the end of each year in the amount of $300,000 for 2014, offset by any cash incentive bonus for the respective year;
|
·
|
All of Mr. Chang's equity awards vest upon a termination in connection with a change in control;
|
·
|
If Mr. Chang is terminated without cause prior to the end of 2014, he will be entitled to the following termination payments in addition to salary and benefits earned prior to termination:
|
(a)
|
Continuation of annual salary and health care coverage and any retention and cash incentive bonuses that would have otherwise been payable, for a period of 12 months; and
|
(b)
|
Vesting of any stock incentive awards that would have otherwise vested during such 12‑month period;
|
·
|
Following his employment, Mr. Chang will be entitled to a four‑year consulting contract with us for $250,000 per year; and
|
·
|
Our obligations under this agreement are contingent upon various restrictive covenants, including, among others, non‑competition, non‑solicitation, non‑endorsement and confidentiality.
|
|
Option Awards
|
Stock Awards
|
||||||||
Name
|
Grant Date
|
Number of Securities Underlying Unexercised Options Exercisable
(#) |
Number of Securities Underlying Unexercised Options Unexercisable
(#)(1)
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
(#)(2)
|
Option Exercise Price
($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested
(#)(3)(5)
|
Market Value of
Shares or Units of
Stock That Have Not Vested ($)(4)
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#)(5)
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested
($)(4)
|
|
|
|
|
|
|
|
|
|
|
|
Truman Hunt
|
2/27/2004
|
25,000
|
—
|
—
|
19.15
|
2/26/2014
|
—
|
—
|
—
|
—
|
|
9/1/2004
|
25,000
|
—
|
—
|
26.13
|
9/1/2014
|
—
|
—
|
—
|
—
|
|
2/28/2005
|
25,000
|
—
|
—
|
22.33
|
2/28/2015
|
—
|
—
|
—
|
—
|
|
8/31/2005
|
25,000
|
—
|
—
|
21.34
|
8/31/2015
|
—
|
—
|
—
|
—
|
|
2/26/2007
|
25,000
|
—
|
—
|
17.75
|
2/26/2014
|
—
|
—
|
—
|
—
|
|
12/20/2007
|
25,000
|
—
|
—
|
16.5
|
12/20/2014
|
—
|
—
|
—
|
—
|
|
2/28/2008
|
25,000
|
—
|
—
|
16.89
|
2/28/2015
|
—
|
—
|
—
|
—
|
|
8/11/2008
|
50,000
|
—
|
—
|
17.03
|
8/11/2015
|
—
|
—
|
—
|
—
|
|
2/27/2009
|
250,000
|
—
|
—
|
9.4
|
2/27/2016
|
—
|
—
|
—
|
—
|
|
6/28/2010
|
18,750
|
6,250
|
—
|
25.89
|
6/28/2017
|
—
|
—
|
—
|
—
|
|
8/31/2010
|
18,750
|
6,250
|
—
|
25.57
|
8/31/2017
|
—
|
—
|
—
|
—
|
|
11/15/2010
|
50,000
|
—
|
—
|
30.43
|
11/15/2017
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
12,500
|
12,500
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
—
|
—
|
—
|
—
|
—
|
18,750
|
2,591,625
|
—
|
—
|
|
8/15/2011
|
12,500
|
12,500
|
—
|
39.35
|
8/15/2018
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
6,250
|
18,750
|
—
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
—
|
—
|
—
|
—
|
—
|
18,750
|
2,591,625
|
37,500
|
5,183,250
|
|
12/17/2012
|
6250
|
18,750
|
—
|
44.83
|
12/17/2019
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
75,000
|
10,366,500
|
|
7/15/2013
|
—
|
—
|
75,000
|
77.65
|
7/15/2020
|
—
|
—
|
—
|
—
|
|
12/9/2013
|
—
|
50,000
|
—
|
131.52
|
12/9/2020
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ritch Wood
|
3/2/2010
|
17,500
|
—
|
—
|
28.09
|
3/2/2017
|
—
|
—
|
—
|
—
|
|
6/28/2010
|
10,312
|
3,438
|
|
25.89
|
6/28/2017
|
—
|
—
|
—
|
—
|
|
8/31/2010
|
10,312
|
3,438
|
—
|
25.57
|
8/31/2017
|
—
|
—
|
—
|
—
|
|
11/15/2010
|
50,000
|
—
|
—
|
30.43
|
11/15/2017
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
6,875
|
6,875
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
13,125
|
4,375
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
—
|
—
|
—
|
—
|
—
|
2,500
|
92,625
|
—
|
—
|
|
8/15/2011
|
6,875
|
6,875
|
—
|
39.35
|
8/15/2018
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
4,375
|
4,375
|
8,750
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
3,438
|
10,312
|
—
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
—
|
—
|
—
|
—
|
—
|
2500
|
92,625
|
5,000
|
691,100
|
|
8/31/2012
|
3,437
|
10,313
|
—
|
41.49
|
8/31/2019
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
17,500
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
|
13,750
|
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
10,000
|
1,382,200
|
|
7/15/2013
|
—
|
—
|
75,000
|
77.65
|
7/15/2020
|
—
|
—
|
—
|
—
|
|
12/9/2013
|
—
|
13,750
|
—
|
131.52
|
12/9/2020
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
Stock Awards
|
||||||||
Name
|
Grant Date
|
Number of Securities Underlying Unexercised Options Exercisable
(#) |
Number of Securities Underlying Unexercised Options Unexercisable
(#)(1)
|
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options
(#)(2)
|
Option Exercise Price
($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested
(#)(3)(5)
|
Market Value of
Shares or Units of
Stock That Have Not Vested ($)(4)
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#)(5)
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested
($)(4)
|
Daniel Chard
|
2/28/2005
|
10,000
|
—
|
—
|
22.33
|
2/28/2015
|
—
|
—
|
—
|
—
|
|
2/28/2008
|
17,500
|
—
|
—
|
16.89
|
2/28/2015
|
—
|
—
|
—
|
—
|
|
8/11/2008
|
17,500
|
—
|
—
|
17.03
|
8/11/2015
|
—
|
—
|
—
|
—
|
|
2/27/2009
|
42,500
|
—
|
—
|
9.4
|
2/27/2016
|
—
|
—
|
—
|
—
|
|
3/2/2010
|
17,500
|
—
|
—
|
28.09
|
3/2/2017
|
—
|
—
|
—
|
—
|
|
6/28/2010
|
10,312
|
3,438
|
—
|
25.89
|
6/28/2017
|
—
|
—
|
—
|
—
|
|
8/31/2010
|
10,312
|
3,438
|
—
|
25.57
|
8/31/2017
|
—
|
—
|
—
|
—
|
|
11/15/2010
|
50,000
|
—
|
—
|
30.43
|
11/15/2017
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
6,875
|
6,875
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
13,125
|
4,375
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
—
|
—
|
—
|
—
|
—
|
2,500
|
345,550
|
—
|
—
|
|
8/15/2011
|
6,875
|
6,875
|
—
|
39.35
|
8/15/2018
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
4,375
|
4375
|
8,750
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
3,438
|
10,312
|
—
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
—
|
—
|
—
|
—
|
—
|
2,500
|
345,550
|
5,000
|
691,100
|
|
8/31/2012
|
3,437
|
10,313
|
—
|
41.49
|
8/31/2019
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
17,500
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
13,750
|
—
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
10,000
|
1,382,200
|
|
7/15/2013
|
—
|
—
|
75,000
|
77.65
|
7/15/2020
|
—
|
—
|
—
|
—
|
|
12/9/2013
|
—
|
13,750
|
—
|
131.52
|
12/9/2020
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
Joseph Chang
|
12/20/2007
|
120,000
|
—
|
—
|
16.5
|
12/19/2014
|
—
|
—
|
—
|
—
|
|
2/27/2009
|
37,500
|
—
|
—
|
9.4
|
2/27/2016
|
—
|
—
|
—
|
—
|
|
11/9/2009
|
—
|
—
|
—
|
—
|
—
|
10,000
|
1,382,200
|
—
|
—
|
|
3/2/2010
|
5,625
|
—
|
—
|
28.09
|
3/2/2017
|
—
|
—
|
—
|
—
|
|
6/28/2010
|
1562
|
1,563
|
—
|
25.89
|
6/28/2017
|
—
|
—
|
—
|
—
|
|
8/31/2010
|
3,125
|
1,563
|
—
|
25.57
|
8/31/2017
|
—
|
—
|
—
|
—
|
|
11/15/2010
|
50,000
|
—
|
—
|
30.43
|
11/15/2017
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
3,125
|
3,125
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
5,625
|
1875
|
—
|
31.92
|
2/28/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
—
|
—
|
—
|
—
|
—
|
1,250
|
172,775
|
—
|
—
|
|
8/15/2011
|
3,125
|
3,125
|
—
|
39.35
|
8/15/2018
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
1875
|
1875
|
3,750
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
1563
|
4,687
|
—
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
—
|
—
|
—
|
—
|
—
|
1,250
|
172,775
|
2,500
|
345,550
|
|
8/31/2012
|
1562
|
4,688
|
—
|
41.49
|
8/31/2019
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
7,500
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
5,000
|
691,100
|
|
2/15/2013
|
—
|
6,250
|
—
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
7/15/2013
|
—
|
—
|
50,000
|
77.65
|
7/15/2020
|
—
|
—
|
—
|
—
|
|
12/9/2013
|
—
|
6,250
|
|
131.52
|
12/9/2020
|
—
|
—
|
—
|
—
|
|
|
|
|
|
|
|
|
|
|
|
Matt Dorny
|
9/1/2004
|
12,500
|
—
|
—
|
26.13
|
9/1/2014
|
—
|
—
|
—
|
—
|
|
2/28/2005
|
12,500
|
—
|
—
|
22.33
|
2/28/2015
|
—
|
—
|
—
|
—
|
|
8/31/2005
|
12,500
|
—
|
—
|
21.34
|
8/31/2015
|
—
|
—
|
—
|
—
|
|
12/20/2007
|
5,000
|
—
|
—
|
16.5
|
12/19/2014
|
—
|
—
|
—
|
—
|
|
2/28/2008
|
5,000
|
—
|
—
|
16.89
|
2/27/2015
|
—
|
—
|
—
|
—
|
|
8/11/2008
|
12,250
|
—
|
—
|
17.03
|
8/11/2015
|
—
|
—
|
—
|
—
|
|
2/27/2009
|
29,750
|
—
|
—
|
9.4
|
2/27/2016
|
—
|
—
|
—
|
—
|
|
3/2/2010
|
7,500
|
—
|
—
|
28.09
|
3/1/2017
|
—
|
—
|
—
|
—
|
|
6/28/2010
|
4,687
|
1,563
|
—
|
25.89
|
6/27/2017
|
—
|
—
|
—
|
—
|
|
8/31/2010
|
4,687
|
1,563
|
—
|
25.57
|
8/30/2017
|
—
|
—
|
—
|
—
|
|
11/15/2010
|
50,000
|
—
|
—
|
30.43
|
11/14/2017
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
3,125
|
3,125
|
—
|
31.92
|
2/27/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
5,625
|
1,875
|
—
|
31.92
|
2/27/2018
|
—
|
—
|
—
|
—
|
|
2/28/2011
|
—
|
—
|
—
|
—
|
—
|
1,250
|
172,775
|
—
|
—
|
|
8/15/2011
|
3,125
|
3,125
|
—
|
39.35
|
8/15/2018
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
1,875
|
5,625
|
—
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
1,563
|
4,687
|
—
|
54.08
|
2/9/2019
|
—
|
—
|
—
|
—
|
|
2/9/2012
|
—
|
—
|
—
|
—
|
—
|
1,250
|
172,775
|
2,500
|
345,550
|
|
8/31/2012
|
1,562
|
4,688
|
—
|
41.49
|
8/31/2019
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
7,500
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
6,250
|
—
|
41.27
|
2/15/2020
|
—
|
—
|
—
|
—
|
|
2/15/2013
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
5,000
|
691,100
|
|
7/15/2013
|
—
|
—
|
50,000
|
77.65
|
7/15/2020
|
—
|
—
|
—
|
—
|
|
12/9/2013
|
—
|
6,250
|
—
|
131.52
|
12/9/2020
|
—
|
—
|
—
|
—
|
(1) | Time-Vesting Options |
Grant
|
Vesting Schedule
|
6/28/2010
|
Vest in four equal annual installments, the first of which vested on February 26, 2011.
|
|
|
2/28/2011
|
Vest in four equal annual installments, the first of which vested on February 15, 2012.
|
|
|
8/15/2011
|
Vest in four equal annual installments, the first of which vested on August 15, 2012.
|
|
|
2/9/2012
|
Vest in four equal annual installments, the first of which vested on February 15, 2013.
|
|
|
8/31/2012
12/17/2012
|
Vest in four equal annual installments, the first of which vested on August 15, 2013.
|
|
|
12/9/2013
|
Vest in four equal annual installments, the first of which vests on August 15, 2014.
|
All other grants
|
Vest in four equal annual installments, the first of which vests one year from the date of grant.
|
Grant
|
Vesting Schedule
|
2/28/2011
|
Two equal tranches became eligible for vesting based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The portions of the first and second tranches that became eligible for vesting were determined by the earnings per share achieved in 2011 and 2012, respectively. The portion of the first tranche that became eligible for vesting vested in two equal annual installments, the first of which vested on March 2, 2012. The portion of the second tranche that became eligible for vesting vests in two equal annual installments, the first of which vested on March 2, 2013.
|
02/09/2012
|
Two equal tranches became eligible for vesting based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The portions of the first and second tranches that became eligible for vesting were determined by the earnings per share achieved in 2012 and 2013, respectively. The portion of the first tranche that became eligible for vesting vested in two equal annual installments, the first of which vested on March 2, 2013. The portion of the second tranche that became eligible for vesting vests in two equal annual installments, the first of which vested on March 2, 2014.
|
2/15/2013
|
Two equal tranches become eligible for vesting based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The portion of the first tranche that becomes eligible for vesting is determined by earnings per share achieved in 2013, ranging from 100% for earnings per share of $3.95 to 50% for earnings per share of $3.70. The portion of the second tranche that becomes eligible for vesting is determined by earnings per share achieved in 2014, ranging from 100% for earnings per share of $4.50 to 50% for earnings per share of $4.15. The portion of the first tranche that becomes eligible for vesting vests in two equal annual installments, the first of which vests on March 2, 2014. The portion of the second tranche that becomes eligible for vesting vests in two equal annual installments, the first of which vests on March 2, 2015. Any portions of the tranches that do not become eligible for vesting will terminate.
|
7/15/2013
|
Vests in four equal tranches based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The first, second, third and fourth tranches vest upon achievement of annualized earnings per share of $6.00, $8.00, $10.00 and $12.00, respectively. The unvested portion of these performance stock options will be terminated if these goals are not achieved based on performance through December 2019, or partially terminated earlier if annualized earnings per share fall below certain thresholds after December 2016.
|
|
|
(3) | Time-Vesting Stock Awards |
Grant
|
Vesting Schedule
|
11/9/2009
|
Vest in five equal annual installments, the first of which vested on December 31, 2010.
|
|
|
All other grants
|
Vest in four equal annual installments, the first of which vests one year from the date of grant.
|
(4) | The market value of the restricted stock units reported in these columns is based on the closing market price of our stock on December 31, 2013, which was $138.22. |
(5) | Performance-Vesting Stock Awards |
Grant
|
Vesting Schedule
|
|
|
2/28/2011
|
Two equal tranches became eligible for vesting based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The portions of the first and second tranches that became eligible for vesting were determined by the earnings per share achieved in 2011 and 2012, respectively. The portion of the first tranche that became eligible for vesting vested in two equal annual installments, the first of which vested on March 2, 2012. The portion of the second tranche that became eligible for vesting vested in two equal annual installments, the first of which vests on March 2, 2013.
|
2/9/2012
|
Two equal tranches became eligible for vesting based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The portions of the first and second tranches that became eligible for vesting were determined by the earnings per share achieved in 2012 and 2013, respectively. The portion of the first tranche that became eligible for vesting vested in two equal annual installments, the first of which vests on March 2, 2013. The portion of the second tranche that became eligible for vesting vests in two equal annual installments, the first of which vested on March 2, 2014.
|
2/15/2013
|
Two equal tranches become eligible for vesting based on the achievement of earnings per share performance levels, measured in terms of diluted earnings per share excluding certain predetermined items. The portion of the first tranche that becomes eligible for vesting is determined by earnings per share achieved in 2013, ranging from 100% for earnings per share of $3.95 to 50% for earnings per share of $3.70. The portion of the second tranche that becomes eligible for vesting is determined by earnings per share achieved in 2014, ranging from 100% for earnings per share of $4.50 to 50% for earnings per share of $4.15. The portion of the first tranche that becomes eligible for vesting vests in two equal annual installments, the first of which vests on March 2, 2014. The portion of the second tranche that becomes eligible for vesting vests in two equal annual installments, the first of which vests on March 2, 2015. Any portions of the tranches that do not become eligible for vesting will terminate.
|
Option Awards
|
Stock Awards
|
|||
Name
|
Number of Shares
Acquired on Exercise
(#) |
Value Realized
on Exercise
($)(1) |
Number of Shares
Acquired on Vesting
(#) |
Value Realized
on Vesting
($)(2) |
Truman Hunt
|
50,000
|
1,229,250
|
75,000
|
3,118,688
|
Ritch Wood
|
105,000
|
11,612,475
|
10,000
|
415,825
|
Dan Chard
|
122,500
|
9,135,172
|
10,000
|
415,825
|
Joe Chang
|
55,563
|
4,929,202
|
15,000
|
1,590,113
|
Matt Dorny
|
25,000
|
2,267,650
|
5,750
|
237,958
|
|
|
|
|
|
(1) | Value realized on exercise of stock options is equal to the number of options exercised multiplied by the market value of our common stock at exercise less the exercise price, and is calculated before payment of any applicable withholding taxes and broker commissions. |
(2) | Value realized on vesting of restricted stock units is equal to the number of restricted stock units vested multiplied by the market value of our common stock on the vesting date, and is calculated before payment of any applicable withholding taxes and broker commissions. |
Name of Fund
|
Rate of Return
|
|
Name of Fund
|
Rate of Return
|
Advisor Managed Portfolio - Conservative Allocation
|
0.59%
|
|
DWS VIP Equity 500 Index - Class A
|
31.93%
|
Advisor Managed Portfolio - Moderate Allocation
|
3.41%
|
|
Fidelity VIP Contrafund - Service Class
|
31.15%
|
Advisor Managed Portfolio - Moderate Growth Allocation
|
7.69%
|
|
American Funds Growth - Class 2
|
30.10%
|
Advisor Managed Portfolio - Growth Allocation
|
11.52%
|
|
LVIP Delaware Special Opportunities - Standard Class
|
33.78%
|
Advisor Managed Portfolio - Aggressive Allocation
|
16.59%
|
|
Fidelity VIP Mid Cap - Service Class
|
36.06%
|
LVIP Money Market - Standard Class
|
0.02%
|
|
Neuberger Berman AMT Mid Cap Growth - I Class
|
32.61%
|
Delaware VIP Limited Term Diversified - Standard Class
|
-1.06%
|
|
Delaware VIP Small Cap Value Series - Standard Class
|
33.51%
|
American Century VP Inflation Protection - Class 2
|
-8.48%
|
|
DWS VIP Small Cap Index - Class A
|
38.64%
|
LVIP Delaware Bond - Standard Class
|
-2.31%
|
|
LVIP Baron Growth Opportunities - Service Class
|
40.06%
|
Delaware VIP High Yield Series - Standard Class
|
9.22%
|
|
American Funds Global Growth - Class 2
|
29.18%
|
FTVIPT Templeton Global Bond Securities - Class 1
|
1.89%
|
|
American Funds Global Small Capitalization - Class 2
|
28.28%
|
LVIP Wilshire Conservative Profile - Standard Class
|
9.75%
|
|
Templeton FTVIPT Growth Securities - Class 1
|
31.05%
|
LVIP Wilshire Moderate Profile - Standard Class
|
11.86%
|
|
AllianceBernstein VPS International Value - Class A
|
23.00%
|
LVIP Wilshire Moderately Aggressive Profile - Standard Class
|
13.55%
|
|
American Funds International - Class 2
|
21.63%
|
Franklin FTVIPT Income Securities - Class 1
|
14.18%
|
|
LVIP MFS International Growth - Standard Class
|
13.61%
|
LVIP SSgA Global Tactical Allocation RPM - Std Class
|
9.81%
|
|
Delaware VIP Emerging Markets Series - Standard Class
|
10.14%
|
Delaware VIP Value Series - Standard Class
|
33.69%
|
|
Delaware VIP REIT Series - Standard Class
|
2.14%
|
Franklin FTVIPT Mutual Shares Securities - Class 1
|
28.53%
|
|
MFS VIT Utilities Series - Initial Class
|
20.52%
|
Name
|
Executive
Contributions
in Last FY
($)(1)
|
Registrant
Contributions
in Last FY
($)(1)
|
Aggregate
Earnings
in Last FY
($)(1)
|
Aggregate
Withdrawals /
Distributions
|
Aggregate
Balance
at Last Fiscal
YE ($)(1)
|
Truman Hunt
|
—
|
82,500
|
378,802
|
—
|
5,319,001
|
—
|
28,000
|
120,846
|
—
|
608,110
|
|
Daniel Chard
|
—
|
26,750
|
82,714
|
—
|
477,331
|
583,000
|
37,500
|
901,731
|
—
|
5,687,225
|
|
Matthew Dorny
|
75,400
|
19,350
|
114,221
|
—
|
640,313
|
(1) | Contribution amounts reflected in this table are and have been reflected in the 2013 Summary Compensation Table and prior years' summary compensation tables, as applicable. Aggregate earnings are not reflected in the 2013 Summary Compensation Table and were not reflected in prior years' summary compensation tables. |
Name
|
Voluntary
Termination
($) |
Involuntary
Termination
for cause
($) |
Involuntary
Termination Not
for cause
($) |
Termination
(Including
Constructive
Termination)
in Connection
With Change
of Control
($) |
Death
($)(1) |
Disability
($) |
Truman Hunt
|
|
|
|
|
|
|
Severance(2)
|
2,000,000
|
—
|
3,250,000
|
4,625,000
|
625,000
|
875,000
|
Equity(3)
|
—
|
—
|
—
|
29,503,125
|
—
|
—
|
Deferred Compensation(4)
|
5,319,001
|
5,319,001
|
5,319,001
|
5,319,001
|
8,752,819
|
5,319,001
|
Health Benefits(5)
|
—
|
—
|
15,306
|
15,306
|
—
|
—
|
Total
|
7,319,001
|
5,319,001
|
8,584,307
|
39,462,432
|
9,377,819
|
6,194,001
|
|
|
|
|
|
|
|
Ritch Wood
|
|
|
|
|
|
|
Severance(2)
|
382,500
|
—
|
1,020,000
|
1,211,250
|
191,250
|
318,750
|
Equity(3)
|
—
|
—
|
—
|
10,752,503
|
—
|
—
|
Deferred Compensation(4)
|
608,110
|
608,110
|
608,110
|
608,110
|
2,355,556
|
608,110
|
Health Benefits(5)
|
—
|
—
|
15,345
|
15,345
|
—
|
—
|
Total
|
990,610
|
608,110
|
1,643,455
|
12,587,208
|
2,546,806
|
926,860
|
Name
|
Voluntary
Termination
($) |
Involuntary
Termination
for cause
($) |
Involuntary
Termination Not
for cause
($) |
Termination
(Including
Constructive
Termination)
in Connection
With Change
of Control
($) |
Death
($)(1) |
Disability
($) |
|
|
|
|
|
|
|
Daniel Chard
|
|
|
|
|
|
|
Severance(2)
|
382,500
|
—
|
1,020,000
|
1,211,250
|
191,250
|
318,750
|
Equity(3)
|
—
|
—
|
—
|
9,092,116
|
—
|
—
|
Deferred Compensation(4)
|
357,999
|
357,999
|
357,999
|
357,999
|
2,345,833
|
357,999
|
Health Benefits(5)
|
—
|
—
|
15,345
|
15,345
|
—
|
—
|
Total
|
740,499
|
357,999
|
1,393,343
|
10,676,709
|
2,537,083
|
676,749
|
|
|
|
|
|
|
|
Joseph Chang
|
|
|
|
|
|
|
Severance(6)
|
1,000,000
|
1,000,000
|
1,630,000
|
1,630,000
|
—
|
1,137,500
|
Equity(3)
|
—
|
—
|
3,886,659
|
7,409,697
|
—
|
—
|
Deferred Compensation(4)
|
5,680,177
|
5,680,177
|
5,680,177
|
5,680,177
|
6,985,700
|
5,680,177
|
Health Benefits(5)
|
—
|
—
|
15,555
|
15,555
|
—
|
—
|
Total
|
6,680,177
|
6,680,177
|
11,212,391
|
14,735,429
|
6,985,700
|
6,817,677
|
|
|
|
|
|
|
|
Matt Dorny
|
|
|
|
|
|
|
Severance(2)
|
315,000
|
—
|
840,000
|
997,500
|
157,500
|
262,500
|
Equity(3)
|
—
|
—
|
—
|
6,027,497
|
—
|
—
|
Deferred Compensation(4)
|
514,725
|
514,725
|
514,725
|
514,725
|
2,031,211
|
514,725
|
Health Benefits(5)
|
—
|
—
|
15,345
|
15,345
|
—
|
—
|
Total
|
829,725
|
514,725
|
1,370,070
|
7,555,067
|
2,188,711
|
777,225
|
(2) | We have employment agreements with Messrs. Hunt, Wood, Chard and Dorny. Among other things, these agreements provide for the following termination payments in addition to salary and benefits earned prior to termination: |
(i) | For Mr. Hunt, continuation of annual salary for a restricted period of up to two years, during which non-solicitation, non-competition and non-endorsement covenants remain in effect; and |
(ii) | For Messrs. Wood, Chard and Dorny, continuation of 75% of annual salary for a restricted period of up to one year, during which non-solicitation, non-competition and non-endorsement covenants remain in effect. |
(i) | A lump sum equal to the pro-rata portion of the executive officer's earned bonus, if any, for each outstanding bonus cycle; |
(ii) | For Mr. Hunt, continuation of annual salary for a period of 24 months; and |
(iii) | For Messrs. Wood, Chard and Dorny, continuation of annual salary for a period of 15 months. |
(i) | A lump sum equal to the pro-rata portion of the executive officer's target bonus for any outstanding bonus cycle; |
(ii) | For Mr. Hunt, a lump sum amount equal to two times annual salary and target bonus; and |
(iii) | For Messrs. Wood, Chard and Dorny, a lump sum amount equal to 1.25 times annual salary and target bonus. |
(i) | A lump sum equal to the pro-rata portion of the executive officer's target bonus for any outstanding bonus cycle; and |
(ii) | Salary continuation for up to 90 days in certain circumstances related to a disability. |
(3) | The amounts payable under the equity category, in the case of stock option awards, are based on the difference between the $138.22 closing price of our stock on December 31, 2013 and the exercise price of the applicable award, multiplied by the number of unvested shares subject to the award. The amounts payable under the equity category in the case of restricted stock units are based on the $138.22 closing price of our stock on December 31, 2013 multiplied by the number of unvested shares subject to the applicable award. |
(4) | The amounts reported for deferred compensation, other than for death or disability, reflect only the amounts deferred by the named executive officers, the vested portion of amounts contributed by us and earnings on such amounts. We may, at our discretion, accelerate vesting of the unvested amounts contributed by us in the event of a change in control. If we were to accelerate vesting, the total amounts of deferred compensation payable to the named executive officers would be as follows: Mr. Hunt, $5,319,001; Mr. Wood, $608,110; Mr. Chard, $477,331; Mr. Chang, $5,680,177 and Mr. Dorny, $633,886. |
(5) | Pursuant to their employment agreements, Messrs. Hunt, Wood, Chard, Chang and Dorny are entitled to a lump sum equal to twelve months of health care continuation coverage upon involuntary termination not for cause (including constructive termination) and termination (including constructive termination) in connection with change in control. |
(6) | We have an employment agreement with Mr. Chang. Among other things, this agreement provides for the following termination payments in addition to salary and benefits earned prior to termination: |
(i) | A four-year consulting contract with us for $250,000 per year; |
(b) | Involuntary termination not for cause (including constructive termination) and termination (including constructive termination) in connection with change in control: |
(i) | Continuation of annual salary for a period of 12 months, subject to optional extension. |
(ii) | Continuation of any retention and cash incentive bonuses that would have otherwise been payable for a period of 12 months. |
(iii) | A four-year consulting contract with us for $250,000 per year, with the first year payment replaced by other severance payments; |
(iv) | All payments are subject to forfeiture for breach of key-employee covenants, including non-competition, non-endorsement, non-solicitation and confidentiality. |
(ii) | Salary continuation for up to 90 days in certain circumstances related to a disability. |
Plan Category
|
Number of securities to be
issued upon exercise of
outstanding options,
warrants and rights
(a)
|
Weighted-average
exercise price of
outstanding options,
warrants and rights
(b)
|
Number of securities
remaining available for future
issuance under equity
compensation plans
(excluding securities reflected
in column (a))
(c)
|
|
|
|
|
Equity compensation plans
approved by security holders |
7,372,578 (1)
|
$46.64
|
2,218,001 (2)
|
|
|
|
|
Equity compensation plans
not approved by security holders |
─
|
─
|
─
|
|
|
|
|
Total
|
7,372,578
|
$46.64
|
2,218,001
|
|
|
|
|
(1) | Consists of 6,642,859 options and 729,719 restricted stock units. Excluding the impact of restricted stock units, which are exercised for no consideration, the weighted‑average exercise price of the outstanding options was $47.10 and the weighted average remaining life of the options was 4.47 years. |
(2) | Consists of 2,218,001 shares available for future issuance under our Amended and Restated 2010 Omnibus Incentive Plan. |
·
|
Continued development of our anti-aging product platform, with plans for the development and launch of new products over the next several years;
|
·
|
The global limited-time offer of our ageLOC TR90 weight management system, which generated approximately $550 million in revenue; and
|
·
|
Accelerated sales force and consumer growth.
|
·
|
The Audit Committee has reviewed and discussed the audited consolidated financial statements and accompanying management's discussion and analysis of financial condition and results of operations with our management and PwC. This discussion included PwC's judgments about the quality, not just the acceptability, of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements.
|
·
|
The Audit Committee also discussed with PwC the matters required to be discussed by Statement on Auditing Standards No. 61, (Communication with Audit Committees), as amended, and as adopted by the PCAOB in Rule 3200T.
|
·
|
Based on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in our Annual Report on Form 10‑K for the year ended December 31, 2013, for filing with the Securities and Exchange Commission.
|
|
|
Fiscal 2013
($)
|
|
Fiscal 2012
($)
|
Audit Fees(1)
|
|
2,908,826
|
|
1,974,756
|
Audit-Related Fees(2)
|
|
25,000
|
|
─
|
Tax Fees(3)
|
|
2,452,139
|
|
2,442,800
|
All Other Fees(4)
|
|
1,800
|
|
1,800
|
Total
|
|
5,387,765
|
|
4,419,356
|
|
|
|
|
|
(1)
|
Audit Fees consist of fees billed for the audit of annual financial statements, review of quarterly financial statements and services normally provided in connection with statutory and regulatory filings or engagements, including services associated with SEC registration statements.
|
(2)
|
Audit-Related Fees consist of fees for the review of audit work papers.
|
(3)
|
Tax Fees consist of approximately $874,639 in fees for tax compliance work and $1,577,500 in fees for tax planning work in 2013 and approximately $945,800 in fees for tax compliance work and $1,497,000 in fees for tax planning work in 2012.
|
(4)
|
All Other Fees consist of annual software license fees.
|